[go: up one dir, main page]

RU93033479A - Способ получения замещенных пирролов, способ получения фармацевтических препаратов - Google Patents

Способ получения замещенных пирролов, способ получения фармацевтических препаратов

Info

Publication number
RU93033479A
RU93033479A RU93033479/04A RU93033479A RU93033479A RU 93033479 A RU93033479 A RU 93033479A RU 93033479/04 A RU93033479/04 A RU 93033479/04A RU 93033479 A RU93033479 A RU 93033479A RU 93033479 A RU93033479 A RU 93033479A
Authority
RU
Russia
Prior art keywords
obtaining
pharmaceutical preparations
substituted pyrroles
active substances
pyrroles
Prior art date
Application number
RU93033479/04A
Other languages
English (en)
Other versions
RU2142460C1 (ru
Inventor
Дейвид Дейвис Питер
Хю Хилл Кристофер
Лотен Джоффрей
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898904161A external-priority patent/GB8904161D0/en
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU93033479A publication Critical patent/RU93033479A/ru
Application granted granted Critical
Publication of RU2142460C1 publication Critical patent/RU2142460C1/ru

Links

Claims (1)

  1. Замещенные пиррола формулы
    Figure 00000001

    в которой R1 - R8, R, X, Y и m имеют указанные в описании значения, являются терапевтически активными веществами, в частности для применения в качестве антивоспалительных, иммунологических, онкологических, бронхолегочных и сердечно-сосудистых активных веществ или в качестве биологически активных веществ для лечения астмы или СПИДа.
RU93033479A 1989-02-23 1990-02-22 Замещенные пирролы и их фармацевтически приемлемые соли RU2142460C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8904161.0 1989-02-23
GB898904161A GB8904161D0 (en) 1989-02-23 1989-02-23 Substituted pyrroles
GB8928210.7 1989-12-13
GB898928210A GB8928210D0 (en) 1989-02-23 1989-12-13 Substituted pyrroles

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU4743198 Division

Publications (2)

Publication Number Publication Date
RU93033479A true RU93033479A (ru) 1996-04-20
RU2142460C1 RU2142460C1 (ru) 1999-12-10

Family

ID=26295005

Family Applications (2)

Application Number Title Priority Date Filing Date
SU904743198A RU2014332C1 (ru) 1989-02-23 1990-02-22 Способ получения замещенных пирролов или их фармацевтически приемлемых солей
RU93033479A RU2142460C1 (ru) 1989-02-23 1990-02-22 Замещенные пирролы и их фармацевтически приемлемые соли

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU904743198A RU2014332C1 (ru) 1989-02-23 1990-02-22 Способ получения замещенных пирролов или их фармацевтически приемлемых солей

Country Status (20)

Country Link
EP (1) EP0384349B1 (ru)
JP (1) JPH06102661B2 (ru)
AT (1) ATE104972T1 (ru)
AU (1) AU633051B2 (ru)
CA (1) CA2010636C (ru)
CZ (1) CZ284587B6 (ru)
DE (1) DE59005491D1 (ru)
DK (1) DK0384349T3 (ru)
DZ (1) DZ1399A1 (ru)
ES (1) ES2052995T3 (ru)
FI (1) FI93447C (ru)
HU (1) HU206351B (ru)
IE (1) IE64184B1 (ru)
IL (1) IL93433A (ru)
MC (1) MC2096A1 (ru)
NO (1) NO174891C (ru)
NZ (1) NZ232589A (ru)
PT (1) PT93246B (ru)
RU (2) RU2014332C1 (ru)
SK (1) SK85590A3 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4128015A1 (de) * 1991-08-23 1993-02-25 Kali Chemie Pharma Gmbh 1,7-anellierte 2-(piperazinoalkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindugnen enthaltende arzneimittel
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
US5721230A (en) * 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
AU678435B2 (en) * 1993-05-10 1997-05-29 F. Hoffmann-La Roche Ag Substituted pyrroles
US5405864A (en) * 1993-10-15 1995-04-11 Syntex (U.S.A.) Inc. Chemotherapeutic maleimides
HUT69164A (en) * 1993-12-07 1995-08-28 Lilly Co Eli Improved process for producing bis-indolyl-maleimide derivatives
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
ES2162843T3 (es) * 1993-12-07 2002-01-16 Lilly Co Eli Inhibidores de la proteina quinasa c.
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
EP0695755B1 (en) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
CA2207404C (en) * 1994-12-13 2004-06-29 F. Hoffmann-La Roche Ag Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
CA2268399C (en) * 1996-10-31 2008-08-19 Harbor Branch Oceanographic Institution, Inc. Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
EP1224932A4 (en) * 1999-08-20 2002-10-16 Sagami Chem Res ACTIVE SUBSTANCES TO INHIBIT CELL DEATH
IL153851A0 (en) 2000-07-27 2003-07-31 Hoffmann La Roche 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
EP1362047B1 (en) 2000-12-08 2006-05-17 Ortho-McNeil Pharmaceutical, Inc. Indazolyl-substituted pyrroline compounds as kinase inhibitors
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
CA2533861A1 (en) 2003-08-08 2005-02-17 Novartis Ag Combinations comprising staurosporines
JP2007518730A (ja) * 2004-01-19 2007-07-12 ノバルティス アクチエンゲゼルシャフト インドリルマレイミド誘導体
WO2006061212A1 (en) 2004-12-08 2006-06-15 Johannes Gutenberg-Universität Mainz 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
CN101941970B (zh) 2005-02-09 2013-08-21 艾科优公司 用于治疗癌症的meleimide衍生物、药物组合物以及方法
ATE496044T1 (de) 2005-07-11 2011-02-15 Novartis Ag Indolylmaleimidderivate
JP4972644B2 (ja) * 2005-08-12 2012-07-11 メルク カナダ インコーポレイテッド Ｃｒｔｈ２受容体拮抗薬としてのインドール誘導体
EP1980561B1 (en) 2007-03-30 2013-10-09 Nerviano Medical Sciences S.R.L. Substituted 1h-pyrazolo[3,4-b] pyridine derivatives active as kinase inhibitors
MX2009013815A (es) 2007-06-22 2010-03-01 Arqule Inc Compuestos de quinazolinona y metodos de uso para los mismos.
CA2690799C (en) * 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
WO2009002807A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Indolyl pyrrolidines for the treatment of cancer
WO2010031183A1 (en) * 2008-09-22 2010-03-25 Merck Frosst Canada Ltd. Indole derivatives as crth2 receptor antagonists
EP2343291A1 (en) 2009-12-18 2011-07-13 Johannes Gutenberg-Universität Mainz 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
US8563567B2 (en) 2009-12-30 2013-10-22 Arqule, Inc. Substituted heterocyclic compounds
EP2474541A1 (en) 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
TN2015000474A1 (en) * 2013-04-23 2017-04-06 Esteve Labor Dr PYRAZINO[1,2-a]INDOLE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
EP3187495A1 (en) 2015-12-30 2017-07-05 Johannes Gutenberg-Universität Mainz 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
US5049563A (en) * 1988-07-07 1991-09-17 Duphar International Research B.V. Annelated indoleketones with an imidazolylalkyl substituent

Similar Documents

Publication Publication Date Title
RU93033479A (ru) Способ получения замещенных пирролов, способ получения фармацевтических препаратов
DE59005491D1 (de) Substituierte Pyrrole.
DE3769379D1 (de) Entzuendungshemmende wirkstoffe, pharmazeutische zusammensetzungen und verfahren zur bekaempfung von entzuendungen.
RU93048636A (ru) 7-/замещенные/-8-/замещенные/-9-/замещенные амино/-6-диметил-6-дезокситетрациклины, промежуточные соединения, способы получения соединений, способ профилактики и лечения и фармацевтическая композиция
IT8547852A0 (it) Ciclosporine,processi per la loro preparazione,uso farmaceutico delle stesse e composizioni farmaceutiche che le contengono
CY2008012I2 (el) Υδροξυεστερες ραπαμυκινης, διαδικασια για τη παρασκευη τους και φαρμακευτικες συνθεσεις περιεχουσες αυτες
RU95115135A (ru) Аналог долостатина
DE68903846D1 (de) Neue galenische form von fenofibrat.
BG97200A (bg) Заместени бензимидазоли,метод за получаването им и тяхното фармацевтично приложение
FI92603B (fi) Mikrobinen menetelmä syklosporiinien valmistamiseksi
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
IT8948430A0 (it) Composti tripeptidici e loro uso farmaceutico come immuno-modulatori
BG92749A (bg) Производни на аминопропанола,метод за тяхното получаване и фармацетични състави,съдържащи тези производни
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
ITRM950143A0 (it) Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di composizioni farmaceutiche antipiretiche ed antinfiammatorie.
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
RU94013447A (ru) НОВЫЕ ЦИС-N-ИМИНОМЕТИЛ-3,4-ДИЗАМЕЩЕННЫЕ- β -ЛАКТАМЫ, СПОСОБЫ ПОЛУЧЕНИЯ, ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ
IT1248838B (it) Soluzioni tampone contenenti collagenasi, loro preparazione ed uso perla diluizione di sieri umani
IT1237501B (it) Politiocarbonati e procedimento per la loro preparazione.
IT8747852A0 (it) Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1231944B (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
NO883381D0 (no) Fremgangsmaate ved fremstilling av n-((4-hydrosy-pyrrolidin-2-on-1-yl)-acetyl)-glycinamid.
RU95115441A (ru) Способ иммунокоррекции
IT1204839B (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione